{
  "pmcid": "10609712",
  "sha256": "7a7087dcf02f24ad1f910dcb20a1a968540d92f146a2705c45763de3e4587c76",
  "timestamp_utc": "2025-11-09T23:07:56.532562+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 8.757210231814547,
    "reading_ease": 50.61663335997869,
    "word_count": 278
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Cementless 3D-Printed vs. Cemented Tibial Components in TKA"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "In this randomised controlled trial, 72 patients were randomised... The sample size was calculated to detect a difference beyond the 0.13 mm measurement error of MTPM with 80% power and 0.05 alpha."
      },
      "Participants": {
        "score": 1,
        "evidence": "72 patients were randomised"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either a cementless 3D-printed Triathlon Tritanium (Stryker) cruciate-retaining (CR) TKA or a cemented Triathlon CR (Stryker) TKA"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome, maximum total point motion (MTPM), was measured using radiostereometric analysis (RSA) at baseline, 3 months, and 1, 2, and 5 years postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Patients and outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "72 patients were randomised"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "At 5 years, the mean MTPM was 0.66 mm (95% CI, 0.56 to 0.78 mm) for the cementless group and 0.53 mm (95% CI, 0.43 to 0.64 mm) for the cemented group (p = 0.09)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events related to the implants were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT02578446"
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Funded by Stryker."
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}